Henry Schein

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgicals, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial on a non-recourse basis, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Henry Schein reports solid Q4 performance and anticipates growth

Henry Schein's Q4 performance showcased growth amidst challenges, with a strategic focus on core margin expansion and strong performance in dental specialties. While facing challenges from declining PPE sales and supply chain issues, the company sees opportunities in stable dental markets and continued growth in operating income. Overall, the company remains optimistic about its outlook for 2023.

Henry Schein reports strong Q1 earnings, eyes growth through acquisitions

Henry Schein's Q1 2023 earnings call highlighted strong financial performance across its dental, medical, and Technology and Value-Added Services businesses. While facing challenges from declining PPE and COVID-19 test kit sales, the company remains optimistic about growth opportunities through acquisitions and stable business segments.

Henry Schein reports solid Q2 results, eyes growth opportunities

Henry Schein's Q2 performance was driven by strong dental sales, while facing challenges from declining PPE and COVID test kit sales. The company is focused on strategic acquisitions and expanding product offerings, with opportunities in technology and specialty products driving growth.

Henry Schein navigates post-cyber incident challenges, focuses on recovery

Henry Schein faced challenges from a cybersecurity incident impacting operations but showcased resilience and recovery efforts across its business segments.
Strategic initiatives focused on customer retention, operational efficiency, and cybersecurity response highlight the company's commitment to long-term growth and stability.
Despite challenges in specific segments and cybersecurity spending variables, Henry Schein's focus on recovery, cost-cutting, and customer trust positions it for future opportunities.
The company's emphasis on digital channels, stable medical demand, and strategic cost-cutting measures underscores its adaptability and strategic vision for sustained growth.

Henry Schein reports resilient Q4 performance and outlines 2024 guidance

Henry Schein's Q4 2023 performance reflects resilience amidst challenges, with a strategic focus on technology, global sales, and recovery post-cyber incident. The company's 2024 outlook includes managing residual cyber impacts and pursuing growth opportunities.

Henry Schein reports solid Q1 earnings, eyes market share expansion

Henry Schein's Q1 performance reflects resilience and growth across key segments, with a focus on market share expansion and profitability. While facing challenges in dental consumables and pricing stability, the company is leveraging opportunities in product portfolio expansion and market positioning. Strategic acquisitions and recovery efforts post-cyber incident are driving competitive strength and customer loyalty.

Henry Schein reports mixed Q2 performance, focuses on cost savings

Henry Schein navigated challenges from a cyber incident, with mixed performance across segments in Q2 2024.
Strong sales growth in dental specialties, focus on cost savings, and resilience in technology services were highlights.
The company's strategic initiatives, financial guidance update, and confidence in future prospects were key takeaways from the call.

Henry Schein excels in Q3 with strategic growth initiatives

Henry Schein's Q3 performance reflects strong market positioning and strategic execution, driving growth across key business segments.
While facing challenges such as LCI sales decline, the company's focus on operational efficiency and cost management remains a priority.
With increased sales guidance, ongoing restructuring initiatives, and strategic capital allocation plans, Henry Schein is poised for continued success and expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Florida and all areas in the projected path of Hurricane Ian that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the hurricane. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein M

Henry Schein Opens Customer Assistance Hotline in Response to Hurricane Ian

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) continued its mission to advance diversity and inclusion in dentistry by recently participating in the Queens County Dental Society Diversity Leadership roundtable, an open forum for leaders from national, state, local, and culturally diverse dental associations to discuss how the dental industry and profession can work together to promote increased diversity in dentistry. The two-day gathering joined representatives from the Na

Henry Schein Continues Its Mission of Advancing Diversity & Inclusion in Dentistry

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced its lineup of products and solutions at the American Association of Oral and Maxillofacial Surgeons (AAOMS) Annual Conference in New Orleans, La. from September 12 through September 17. Visitors at Henry Schein's booth (#801) can explore the Company's vast surgical product offerings that help meet the unique needs of oral surgeons, and attendees can speak with Henry Schein Dental representatives as well as Henry

Henry Schein to Showcase Diverse Portfolio of Products at the AAOMS Annual Conference, Sept. 12 – 17, 2022

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the 25th anniversary of its “Back to School” program, which provides backpacks, school supplies, and more to support the back-to-school needs of underserved children and their families. Since the program's inception in 1998, the Company has helped more than 65,000 children start a new school year with confidence. This year, Team Schein Members at 34 locations, including 21 U.S. facilities and 13 international sit

Henry Schein Celebrates 25 Years of Its ‘Back to School' Program

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

Why Is Henry Schein (HSIC) Down 1.5% Since Last Earnings Report?

Henry Schein's (HSIC) acquisition of Midway Dental Supply complements its efforts to offer products and services that deliver more effective, high-quality patient care.

Henry Schein (HSIC) Inks Deal to Acquire Midway Dental Supply

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein acquires Midway Dental Supply and strengthens its long-standing presence in the Midwestern U.S.

Henry Schein Acquires Midway Dental Supply

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to present at two investor conferences in September.

Henry Schein to Present at Two Investor Conferences in September

Henry Schein, Inc. offers a resiliency factor to equity portfolios amid the current macro climate. Those seeking to scale up weighting to defensives and reduce portfolio variance might consider the long-term cash compounder.

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios

Americans need to start going to the dentist again, which should help dental supplier Henry Schein.

Drilling Down on Henry Schein

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the publication of its 2021 Sustainability and Corporate Social Responsibility (CSR) Report, titled “BOLD Leadership for a Healthier World.” The Company's 2021 Sustainability and CSR Report details work done over the past year to advance its environmental, social, and governance (ESG) stewardship, including ex

Henry Schein Advances ESG Stewardship

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein announces $400 million increase to share repurchase plan.

Henry Schein Announces $400 Million Increase to Share Repurchase Plan

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein announces the passing of board member E. Dianne Rekow, DDS, Ph.D.

Henry Schein Announces the Passing of Board Member E. Dianne Rekow

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Kentucky that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the recent floods. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein Members from 8 a.m. to 6 p.m. Eastern Time. “Our

Henry Schein Opens Customer Assistance Hotline in Response to Kentucky Floods

Henry Schein (HSIC) reports better-than-expected Q2 earnings with impressive sales growth across the Medical and Technology and Value-added Services segments.

Henry Schein (HSIC) Q2 Earnings Top Estimates, '22 EPS View Up

Henry Schein, Inc. (NASDAQ:HSIC ) Q2 2022 Earnings Conference Call August 2, 2022 10:00 AM ET Company Participants Graham Stanley - Vice President of Investor Relations & Strategic Financial Project Officer Stanley Bergman - Executive Chairman & Chief Executive Officer Ron South - Senior Vice President & Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Andrew Brackmann - William Blair Jon Block - Stifel Jeff Johnson - Baird A.J. Rice - Credit Suisse Operator Good morning, ladies and gentlemen, and welcome to Henry Schein's Second Quarter 2022 Earnings Conference Call.

Henry Schein, Inc. (HSIC) CEO Stanley Bergman on Q2 2022 Results - Earnings Call Transcript

Henry Schein (HSIC) delivered earnings and revenue surprises of 3.57% and 2.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Henry Schein (HSIC) Beats Q2 Earnings Estimates

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein reports record second-quarter 2022 financial results.

Henry Schein Reports Record Second-Quarter 2022 Financial Results

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein names Mark Hillebrandt Chief Digital Revenue Officer.

Henry Schein Names Mark Hillebrandt Chief Digital Revenue Officer

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein appoints Trinh Clark and Leigh Benowitz to Executive Management Committee.

Henry Schein Appoints Trinh Clark and Leigh Benowitz to Executive Management Committee

Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can Henry Schein (HSIC) Keep the Earnings Surprise Streak Alive?

Henry Schein's (HSIC) Q2 performance will likely reflect continued strength in its dental and medical businesses.

Henry Schein (HSIC) to Report Q2 Earnings: What's in Store?

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Henry Schein (HSIC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Henry Schein (HSIC) serves the Swiss dental implant market through its Basel-based division, Camlog Biotechnologies GmbH, since 2004.

Henry Schein's (HSIC) New Buyout Expands Its Switzerland Base

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to webcast its second-quarter 2022 conference call on Tuesday, August 2, 2022.

News for Henry Schein Stock (HSIC)